Finance

Roche to acquire liver drug developer 89bio for up to $3.5 billion

Roche to acquire liver drug developer 89bio for up to $3.5 billion

FRANKFURT (Reuters) -Roche said on Thursday it agreed to acquire U.S. biotech firm 89bio In a statement, the Swiss drugmaker said the deal was worth about $2.4 billion, or up to $3.5 billion when...

Read More
Huawei Unveils New AI Chip Tech to Challenge Nvidia’s Lead

Huawei Unveils New AI Chip Tech to Challenge Nvidia’s Lead

The new SuperPod technology can support linking as many as 15,488 graphic cards containing Huawei’s Ascend-branded artificial intelligence chips. Photographer: Long Wei/ Feature China/Future P...

Read More
Analysis-Fed’s rate cut comes with caveats, leaving investors lukewarm

Analysis-Fed’s rate cut comes with caveats, leaving investors lukewarm

By Davide Barbuscia and Suzanne McGee NEW YORK (Reuters) -Investors look set to face a volatile few months ahead after the Federal Reserve resumed interest rate cuts and opened the door to furthe...

Read More
BOJ may raise rates in October even if Takaichi wins leadership race, says ex-central bank official

BOJ may raise rates in October even if Takaichi wins leadership race, says ex-central bank official

By Leika Kihara TOKYO (Reuters) -The Bank of Japan could raise interest rates in October even if Sanae Takaichi, a proponent of aggressive monetary easing, wins the ruling party’s leadership...

Read More
Spirit Airlines is cutting flights by 25% as it restructures again

Spirit Airlines is cutting flights by 25% as it restructures again

Spirit Airlines will cut a fourth of its flights, CEO Dave Davis said in a memo to staff. From November, the budget airline will focus its operations on its strongest markets. Davis also hin...

Read More